Navigation Links
NCPA Statement on Wal-Mart's Entry Into the Pharmacy Benefit Market
Date:1/25/2008

ALEXANDRIA, Va., Jan. 25 /PRNewswire-USNewswire/ --- In a speech earlier this week, Wal-Mart Chief Executive Officer Lee Scott revealed the company was in the initial stages of offering pharmacy benefit manager services. In response Bruce Roberts, RPh, executive vice president and CEO of the National Community Pharmacists Association (NCPA) issued the following statement:

"The PBM industry badly needs to be reformed. The current PBM business model is one that lacks transparency and has come under fire in multiple legal proceedings such as when Medco Health Solutions agreed to pay the U.S. Government $155 million in December 2006 for alleged illegal behavior involving false claims and kickbacks. That is why NCPA has been at the forefront of pushing legislative solutions at the federal and state level to empower community pharmacies with the type of business negotiations rights that would shield patients from many of the unscrupulous PBM practices.

"Wal-Mart, a true corporate behemoth and the nation's third largest pharmacy retailer, has decided to become players in the PBM industry. They will have a dramatic affect on whether positive or negative changes occur. For example, PBMs are notorious for pushing patients to use the mail order pharmacies they actually own, which is a conflict of interest that is not to the patient's benefit. Another example of questionable PBM activities is the undue influence pharmaceutical manufacturers have in getting specific, often more expensive drugs utilized even when they are not part of the prescription plan formulary. This happens because of rebates the PBMs receive when these switches are successful. The list of dubious behavior by PBMs is extensive, but the common theme seems to be a relentless quest for profits regardless of what's in the best interest of patients.

"Wal-Mart has the opportunity to provide a positive influence on the PBM marketplace. Its pockets are deep and its sheer size causes industries to take notice. It can use its market influence to re-shape the PBM industry to one that is transparent and truly seeks solutions that will benefit the patient. We have seen such examples with other PBMs such as Community CCRx, which uses a pharmacy driven model to benefit the patient, pharmacy, and plan. Wal-Mart would do well to emulate such a plan.

"Wal-Mart's track record in healthcare is not strong. Employees have questioned the healthcare benefits it provides. It has commoditized prescription medications by selling prescription medications below its cost. It has engaged in predatory pricing that has hurt small business healthcare providers. In the best interests of the consumer, NCPA challenges Wal-Mart to use their entry into the PBM marketplace to establish standards that provide transparency, exercise fiduciary responsibility on behalf of payers, and work with pharmacy to optimize the health benefits medications provide. We will be watching with great interest to see the course Wal-Mart chooses to take."

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... , April 20, 2017 Research ... America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, ... Segment Forecasts, 2014 - 2025" report to their offering. ... The Latin American ... 21.0 billion by 2025 Low drug registration cost ...
(Date:4/19/2017)... -- The Mobile X-Ray product segment is the most attractive ... forecast period Mobile X-Ray segment is the largest ... devices market, which is estimated to be valued at more ... of 7% over the forecast period. Mobile X-Ray segment is ... 100 Mn in 2017 over 2016. The segment,s revenue in ...
Breaking Medicine Technology: